The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

“…158,[174][175][176] If considering the use of bleomycin, pulmonary function tests are recommended. 158,159 The 4-cycle BEP regimen is recommended (category 2A) as the standard regimen.…”

Juvenile granulosa cell tumour: a rare clinical entity

“…Taxane and platinum combination chemotherapy warrants further investigation in this disease. 10 The use of radiotherapy has not been shown to confer any survival benefit to JGCT at any stage. Finally, surgery continues to be the primary corner stone of initial treatment with chemotherapy being reserved for advanced or recurrent disease states.…”

Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies

“…The BEP regimen is active in recurrent or incompletely resected SLCT, but does not offer durable remissions (63). Taxanes may be an effective alternative, with less toxicity compared to BEP in a retrospective study (50).…”

“…BEP is the most accepted regimen in this setting (16), as well as for recurrent disease that is refractory to hormone therapy (46,49). The potential activity of taxanes has been studied in this disease (50) and the combination of carboplatin and paclitaxel, is not unreasonable. Reported response rates to chemotherapeutic regimens are summarized in Table III.…”